Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discovery.

Journal of biomedical informatics - 1 Aug 2015

Xu Rong, Wang QuanQiu

Abstract excerpt

Schizophrenia (SCZ) is a common complex disorder with poorly understood mechanisms and no effective drug treatments. Despite the high prevalence and vast unmet medical need represented by the disease, many drug companies have moved away from the development of drugs for SCZ. Therefore, alternative strategies are needed for the discovery of truly innovative drug treatments for SCZ. Here, we present a disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Area Under Curve
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Delivery Systems

Share to Drug Discovery

Share to Drug Repositioning

Share to Knowledge Bases

Share to United States Food and Drug Administration

Source

Open in PubMed Open full text

Identifiers

PMID: 26151312
DOI: 10.1016/j.jbi.2015.06.027
PMCID: PMC4589865

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discovery.PMID 26151312Read ↗

Disease comorbidity-guided drug repositioning: a case study in schizophrenia.Semantic proximity Read ↗

Uncovering novel therapeutics for schizophrenia: a multitarget approach using the CANDO platformSemantic proximity Read ↗

When GWAS meets the Connectivity Map: drug repositioning for seven psychiatric disordersSemantic proximity Read ↗

Multi-Trait Genetic Insights Into Schizophrenia Across Ancestries: Genome-Wide Association Meta-Analyses, Machine Learning, and Drug Repurposing Study.Semantic proximity Read ↗

Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.Semantic proximity Read ↗

Translating GWAS Findings Into Therapies For Depression And Anxiety Disorders: Drug Repositioning Using Gene-Set Analyses Reveals Enrichment Of Psychiatric Drug ClassesSemantic proximity Read ↗

Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and CompoundsSemantic proximity Read ↗

Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds.Semantic proximity Read ↗

Identifying drug targets for schizophrenia through gene prioritization.Semantic proximity Read ↗

Pathway and network embedding methods for prioritizing psychiatric drugsSemantic proximity Read ↗

Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study.Semantic proximity Read ↗

Potentially repurposable drugs for schizophrenia identified from its interactomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.